Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non-small cell lung cancer
Oscar Arrieta et al.
CANCER MEDICINE (2020)
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
Branimir Sikic et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Macrophages induce CD47 upregulation via IL-6 and correlate with poor survival in hepatocellular carcinoma patients
Jing Chen et al.
ONCOIMMUNOLOGY (2019)
Checkpoint CD47 Function On Tumor Metastasis And Immune Therapy
Shu Lian et al.
ONCOTARGETS AND THERAPY (2019)
Prognostic significance of CD47 in human malignancies: a systematic review and meta-analysis
Hui-Jun Zhao et al.
TRANSLATIONAL CANCER RESEARCH (2018)
Cancer immunotherapy targeting the CD47/SIRPα axis
Kipp Weiskopf
EUROPEAN JOURNAL OF CANCER (2017)
Is CD47 an innate immune checkpoint for tumor evasion?
Xiaojuan Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
Sharareh Gholamin et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Anti-CD47 antibody suppresses tumour growth and augments the effect of chemotherapy treatment in hepatocellular carcinoma
Jessica Lo et al.
LIVER INTERNATIONAL (2016)
CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
Kipp Weiskopf et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma
Zhenyu Xiao et al.
CANCER LETTERS (2015)
Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice
Jessica Lo et al.
HEPATOLOGY (2015)
Blockade of CD47-Mediated Cathepsin S/Protease-Activated Receptor 2 Signaling Provides a Therapeutic Target for Hepatocellular Carcinoma
Terence Kin-Wah Lee et al.
HEPATOLOGY (2014)
Treatment of intermediate-stage hepatocellular carcinoma
Alejandro Fomer et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients
Irene Baccelli et al.
ONCOTARGET (2014)
The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications
Mark P. Chao et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
A New Therapeutic Target for Leukemia Comes to the Surface
David S. Ritchie et al.
CELL (2009)
Functions and molecular mechanisms of the CD47-SIRPα signalling pathway
Takashi Matozaki et al.
TRENDS IN CELL BIOLOGY (2009)
Share Paper
